150 related articles for article (PubMed ID: 38773643)
1. High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial).
Zegers CML; Swinnen A; Roumen C; Hoffmann AL; Troost EGC; van Asch CJJ; Brandts L; Compter I; Dieleman EMT; Dijkstra JB; Granzier M; Hendriks M; Hofman P; Houben RMA; Ramaekers B; Ronner HE; Rouhl RPW; van der Salm S; Santegoeds RGC; Verhoeff JJ; Wagner GL; Zwemmer J; Schijns O; Colon AJ; Eekers DBP
Trials; 2024 May; 25(1):334. PubMed ID: 38773643
[TBL] [Abstract][Full Text] [Related]
2. Surgery for epilepsy.
West S; Nevitt SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010541. PubMed ID: 31237346
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
4. Surgery for epilepsy.
West S; Nolan SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
Cochrane Database Syst Rev; 2015 Jul; (7):CD010541. PubMed ID: 26130264
[TBL] [Abstract][Full Text] [Related]
5. Low-dose radiosurgery or hypofractionated stereotactic radiotherapy as treatment option in refractory epilepsy due to epileptogenic lesions in eloquent areas - Preliminary report of feasibility and safety.
Boström JP; Delev D; Quesada C; Widman G; Vatter H; Elger CE; Surges R
Seizure; 2016 Mar; 36():57-62. PubMed ID: 26950169
[TBL] [Abstract][Full Text] [Related]
6. Evidence on the efficacy of primary radiosurgery or stereotactic radiotherapy for drug-resistant non-neoplastic focal epilepsy in adults: A systematic review.
Eekers DBP; Pijnappel EN; Schijns OEMG; Colon A; Hoeben A; Zindler JD; Postma AA; Hoffmann AL; Lambin P; Troost EGC
Seizure; 2018 Feb; 55():83-92. PubMed ID: 29414140
[TBL] [Abstract][Full Text] [Related]
7. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Protocol of a prospective multicenter randomized controlled trial of robot-assisted stereotactic lesioning in the treatment of focal drug-resistant epilepsy.
Gong M; Xu K; Shan Y; Wang Y; Zhang C; Wang X; Zhou J; Guan Y; Li T; Luan G
Trials; 2023 Jun; 24(1):387. PubMed ID: 37296479
[TBL] [Abstract][Full Text] [Related]
10. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Ramaratnam S; Marson AG
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD001909. PubMed ID: 32196639
[TBL] [Abstract][Full Text] [Related]
12. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin add-on for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Hemming K; Marson AG
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
[TBL] [Abstract][Full Text] [Related]
14. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE;
Lancet; 2021 Apr; 397(10282):1363-1374. PubMed ID: 33838757
[TBL] [Abstract][Full Text] [Related]
15. QUality of life and Economic evaluation after neuroSTimulation for Epilepsy (QUESTE) in adolescents and adults with drug-resistant epilepsy: protocol for a multicentre, prospective observational cohort study in The Netherlands.
Smeets JJAS; Rijkers K; Ackermans L; Schijns O; van Mastrigt GAPG; Rouhl R; Wagner GL; van Kuijk S; Nelissen J; van Straaten IECW; Kho K; Snoeijen-Schouwenaars F; Meppelink AM; Klinkenberg S; Majoie HJM
BMJ Open; 2023 Jun; 13(6):e071575. PubMed ID: 37280021
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Weston J; Marson AG
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of epilepsy surgery in children and adolescents with drug resistant focal epilepsy at three years in a tertiary care epilepsy center in Thailand.
Anurat K; Khongkhatithum C; Pattanaprateep O; Chamroonrat W; Boongird A; Visudtibhan A; Thampratankul L
J Clin Neurosci; 2020 Sep; 79():163-168. PubMed ID: 33070889
[TBL] [Abstract][Full Text] [Related]
18. Oxcarbazepine add-on for drug-resistant focal epilepsy.
Bresnahan R; Atim-Oluk M; Marson AG
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012433. PubMed ID: 32129501
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin add-on for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Marson AG
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD005612. PubMed ID: 35349176
[TBL] [Abstract][Full Text] [Related]
20. Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial.
Tomita N; Ishiyama H; Makita C; Ohshima Y; Nagai A; Baba F; Kuno M; Otsuka S; Kondo T; Sugie C; Kawai T; Takaoka T; Okazaki D; Torii A; Niwa M; Kita N; Takano S; Kawakami S; Matsuo M; Kumano T; Ito M; Adachi S; Abe S; Murao T; Hiwatashi A
BMC Cancer; 2022 Dec; 22(1):1259. PubMed ID: 36471274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
